World's Best Scientists 2026 revealed!
James E. Tcheng

James E. Tcheng

D-Index & Metrics

Medicine

D-Index
94
Citations
31850
World Ranking
10499
National Ranking
5404

James E. Tcheng publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James E. Tcheng sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 396 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James E. Tcheng D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James E. Tcheng sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2018 - Distinguished Service Award, American College of Cardiology (ACC)

Overview

James E. Tcheng is affiliated with Duke University in the United States and conducts research primarily in the field of Medicine, with a specific focus on Cardiology and Cardiovascular Medicine, Biomedical Engineering, Surgery, Public Health, Environmental and Occupational Health, and Economics and Econometrics.

Their recent scholarly contributions include:

  • Telehealth transformation: COVID-19 and the rise of virtual care, 2020, Journal of the American Medical Informatics Association
  • Systematic review of current natural language processing methods and applications in cardiology, 2021, Heart
  • Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions, 2023, JACC: Cardiovascular Interventions
  • Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative, 2020, Therapeutic Innovation & Regulatory Science
  • Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks, 2022, BMJ Surgery Interventions & Health Technologies

Their work covers several main topics, most notably:

  • Quality and Safety in Healthcare
  • Biomedical and Engineering Education
  • Artificial Intelligence in Healthcare and Education
  • Health Systems, Economic Evaluations, Quality of Life
  • Electronic Health Records Systems
  • Peripheral Artery Disease Management
  • Coronary Interventions and Diagnostics

Tcheng frequently publishes in venues such as:

  • BMJ Surgery Interventions & Health Technologies
  • Medical Devices Evidence and Research
  • International Journal of Translational Medical Research and Public Health
  • Journal of Vascular Surgery
  • Journal of the American College of Cardiology

The scientist has collaborated on multiple occasions with coauthors including Jens Eldrup-Jørgensen, Joseph P. Drozda, Philip P. Goodney, Gregory Pappas, and Jove Graham.

In 2018, James E. Tcheng received the Distinguished Service Award from the American College of Cardiology (ACC).

Best Publications

  • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

    Gregg W. Stone;Cindy L. Grines;David A. Cox;Eulogio Garcia

  • Telehealth transformation: COVID-19 and the rise of virtual care.

    Jedrek Wosik;Marat Fudim;Blake Cameron;Ziad Gellad;Ziad Gellad

  • 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

    Karen A. Hicks;James E. Tcheng;Biykem Bozkurt;Bernard R. Chaitman

  • Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

    Giuseppe De Luca;Harry Suryapranata;Gregg W. Stone;David Antoniucci

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

    Karen A. Hicks;Kenneth W. Mahaffey;Roxana Mehran;Steven E. Nissen

  • Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.

    Amir Halkin;Mandeep Singh;Eugenia Nikolsky;Cindy L. Grines

  • Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

    Paul Sorajja;Bernard J Gersh;David A Cox;Michael G McLaughlin

  • Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

    J E Tcheng;S G Ellis;B S George;D J Kereiakes

  • Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention

    Eric J. Topol;James J. Ferguson;Harlan F. Weisman;James E. Tcheng

  • Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction

    H. Mehrdad Sadeghi;Gregg W. Stone;Cindy L. Grines;Roxana Mehran

  • Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

    Steven R. Steinhubl;J. David Talley;Gregory A. Braden;James E. Tcheng

  • Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

    Lincoff Am;Califf Rm;Moliterno Dj;Ellis Sg

  • Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart Disease

    David F. Kong;Robert M. Califf;Dave P. Miller;David J. Moliterno

  • Restenosis after coronary angioplasty: An overview

    Robert M. Califf;Donald F. Fortin;David J. Frid;William R. Harlan

  • Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention

    James E. Tcheng;Robert A. Harrington;Kandice Kottke-Marchant;Neal S. Kleiman

  • Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial

    David R. Holmes;Michael Savage;J. M. LaBlanche;Lars Grip

  • Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: Consensus Definitions From Peripheral Academic Research Consortium (PARC)

    Manesh R. Patel;Michael S. Conte;Donald E. Cutlip;Nabil Dib

  • Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction.

    James E. Tcheng;John D. Jackman;Charlotte L. Nelson;Laura H. Gardner

  • Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

    Eugenia Nikolsky;Eve D. Aymong;Amir Halkin;Cindy L. Grines

  • Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.

    Topol Ej;Ferguson Jj;Weisman Hf;Tcheng Je

Frequent Co-Authors

Robert M. Califf
Robert M. Califf Duke University
Gregg W. Stone
Gregg W. Stone Icahn School of Medicine at Mount Sinai
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
David A. Cox
David A. Cox University of Alabama at Birmingham
Eulogio García
Eulogio García Hospital Clínico San Carlos
Alexandra J. Lansky
Alexandra J. Lansky Yale University
Eric J. Topol
Eric J. Topol Scripps Research Institute
Cindy L. Grines
Cindy L. Grines Wayne State University
Giulio Guagliumi
Giulio Guagliumi ASST Papa Giovanni XXIII Hospital
A. Michael Lincoff
A. Michael Lincoff Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers diverse pathways beyond traditional doctor training. Many students consider online medical coding classes with financial aid, which prepare graduates for in-demand roles in hospitals or clinics while offering flexible learning options and support to manage costs.

Nursing is another popular field. Some aspiring nurses want to avoid extensive entrance exams, making nursing schools that don't require teas or hesi a top choice. This opens doors for those ready to jump into clinical training without added testing barriers.

For those interested in the business side of healthcare, earning a health care administration degree online can lead to management positions. These programs are perfect for working professionals aiming to advance their careers at their own pace.

Registered nurses looking to grow can explore adn to np bridge programs, which fast-track the journey from an associate degree to a master’s level nurse practitioner role.

These online degree options provide accessible entry points into healthcare careers, allowing students to find the right balance between flexibility, cost, and professional goals.

Best Scientists Citing James E. Tcheng

Trending Scientists

Recently Published Articles